Derivatives of 4-methyl-1,2,3-benzoxathiazine 2,2-dioxide as selective inhibitors of human carbonic anhydrases IX and XII over the cytosolic isoforms I and II

References

• Elbadawi MM, Eldehna WM, Nocentini A, Somaa WR, Al-Rashood ST, Elkaeed EB, El Hassab MA, Abdel-Aziz HA, Supuran CT, Fares M. Development of 4-((3-oxo-3-phenylpropyl)amino)benzenesulfonamide derivatives utilizing tail/dual-tail approaches as novel carbonic anhydrase inhibitors. Eur J Med Chem. 2022;238:114412.
   PubMed Web of Science ®Google Scholar
• Singh P, Sridhar Goud N, Swain B, Kumar Sahoo S, Choli A, Angeli A, Singh Kushwah B, Madhavi Yaddanapudi V, Supuran CT, Arifuddin M. Synthesis of a new series of quinoline/pyridine indole-3-sulfonamide hybrids as selective carbonic anhydrase IX inhibitors. Bioorg Med Chem Lett. 2022;70:128809.
   PubMed Web of Science ®Google Scholar
• Siwach K, Kumar A, Panchal H, Kumar R, Bhardwaj JK, Angeli A, Supuran CT, Sharma PK. Selective inhibition of carbonic anhydrase IX by sulphonylated 1,2,3-triazole incorporated benzenesulphonamides capable of inducing apoptosis. J Enzyme Inhib Med Chem. 2022;37(1):1454–1463.
   PubMed Web of Science ®Google Scholar
• Angeli A, Carta F, Nocentini A, Winum JY, Zalubovskis R, Akdemir A, Onnis V, Eldehna WM, Capasso C, Simone G, et al. Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment. Metabolites. 2020;10(10):412.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Angeli A, Carta F, Winum JY, Zalubovskis R, Carradori S, Capasso C, Donald WA, Supuran CT. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem. 2021;36(1):561–580.
   PubMed Web of Science ®Google Scholar
• Buabeng ER, Henary M. Developments of small molecules as inhibitors for carbonic anhydrase isoforms. Bioorg Med Chem. 2021;39:116140.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Taghour MS, Al-Warhi T, Nocentini A, Elbadawi MM, Mahdy HA, Abdelrahman MA, Alotaibi OJ, Aljaeed N, Elimam DM, et al. Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms. J Enzyme Inhib Med Chem. 2022;37(1):531–541.
   PubMed Web of Science ®Google Scholar
• Pastorek J, Pastoreková S, Callebaut I, Mornon JP, Zelník V, Opavský R, Zat’ovicová M, Liao S, Portetelle D, Stanbridge EJ, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene. 1994;9:2877–2888.
   PubMed Web of Science ®Google Scholar
• Türeci O, Sahin U, Vollmar E, Siemer S, Göttert E, Seitz G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, et al. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci U S A. 1998;95(13):7608–7613.
   PubMed Web of Science ®Google Scholar
• Kumar A, Siwach K, Supuran CT, Sharma PK. A decade of tail-approach based design of selective as well as potent tumor associated carbonic anhydrase inhibitors. Bioorg Chem. 2022;126:105920.
   PubMed Web of Science ®Google Scholar
• Becker HM, Deitmer JW. Proton Transport in Cancer Cells: The Role of Carbonic Anhydrases. IJMS. 2021;22(6):3171.
   Google Scholar
• Tawfik HO, Shaldam MA, Nocentini A, Salem R, Almahli H, Al-Rashood ST, Supuran CT, Eldehna WM. Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity. J Enzyme Inhib Med Chem. 2022;37(1):1043–1052.
   PubMed Web of Science ®Google Scholar
• Lomelino CL, Supuran CT, McKenna R. Non-classical inhibition of carbonic anhydrase. IJMS. 2016;17(7):1150.
   Google Scholar
• Aimene Y, Eychenne R, Rodriguez F, Mallet-Ladeira S, Saffon-Merceron N, Winum J-Y, Nocentini A, Supuran CT, Benoist E, Seridi A. Synthesis, crystal structure, inhibitory activity and molecular docking of coumarins/sulfonamides containing triazolyl pyridine moiety as potent selective carbonic anhydrase IX and XII inhibitors. Crystals. 2021;11(9):1076.
   Web of Science ®Google Scholar
• Maresca A, Temperini C, Vu H, Pham NB, Poulsen SA, Scozzafava A, Quinn RJ, Supuran CT. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc. 2009;131(8):3057–3062.
   PubMed Web of Science ®Google Scholar
• Tars K, Vullo D, Kazaks A, Leitans J, Lends A, Grandane A, Zalubovskis R, Scozzafava A, Supuran CT. Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases. J Med Chem. 2013;56(1):293–300.
   PubMed Web of Science ®Google Scholar
• Grandane A, Tanc M, Zalubovskis R, Supuran CT. Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII. Bioorg Med Chem. 2014;22(5):1522–1528.
   PubMed Web of Science ®Google Scholar
• Grandane A, Tanc M, Zalubovskis R, Supuran CT. 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII. Bioorg Med Chem Lett. 2014;24(5):1256–1260.
   PubMed Web of Science ®Google Scholar
• Grandane A, Tanc M, Žalubovskis R, Supuran CT. Synthesis of 6-aryl-substituted sulfocoumarins and investigation of their carbonic anhydrase inhibitory action. Bioorg Med Chem. 2015;23(7):1430–1436.
   PubMed Web of Science ®Google Scholar
• Grandane A, Tanc M, Di Cesare Mannelli L, Carta F, Ghelardini C, Žalubovskis R, Supuran CT. 6‑Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells. J Med Chem. 2015;58(9):3975–3983.
   PubMed Web of Science ®Google Scholar
• Grandāne A, Nocentini A, Domračeva I, Žalubovskis R, Supuran CT. Development of oxathiino[6,5-b]pyridine 2,2-dioxide derivatives as selective inhibitors of tumor-related carbonic anhydrases IX and XII. Eur J Med Chem. 2020;200:112300.
   PubMed Web of Science ®Google Scholar
• Krasavin M, Žalubovskis R, Grandāne A, Domračeva I, Zhmurov P, Supuran CT. Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX/XII and of human thioredoxin reductase. J Enzyme Inhib Med Chem. 2020;35(1):506–510.
   PubMed Web of Science ®Google Scholar
• Pustenko A, Stepanovs D, Žalubovskis R, Vullo D, Kazaks A, Leitans J, Tars K, Supuran CT. 3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem. 2017;32(1):767–775.
   PubMed Web of Science ®Google Scholar
• Pustenko A, Nocentini A, Balašova A, Alafeefy A, Krasavin M, Žalubovskis R, Supuran CT. Aryl derivatives of 3H-1,2-benzoxathiepine 2,2-dioxide as carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem. 2020;35(1):245–254.
   PubMed Web of Science ®Google Scholar
• Pustenko A, Nocentini A, Balašova A, Krasavin M, Žalubovskis R, Supuran CT. 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors. J Enzyme Inhib Med Chem. 2020;35(1):650–656.
   PubMed Web of Science ®Google Scholar
• Podolski-Renić A, Dinić J, Stanković T, Jovanović M, Ramović A, Pustenko A, Žalubovskis R, Pešić M. Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance. Eur J Pharm Sci. 2019;138:105012.
   PubMed Web of Science ®Google Scholar
• Grandane A, Nocentini A, Werner T, Zalubovskis R, Supuran CT. Benzoxepinones: A new isoform-selective class of tumor associated carbonic anhydrase inhibitors. Bioorg Med Chem. 2020;28(11):115496.
   PubMed Web of Science ®Google Scholar
• Onyılmaz M, Koca M, Bonardi A, Degirmenci M, Supuran CT. Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors. J Enzyme Inhib Med Chem. 2022;37(1):743–748.
   PubMed Web of Science ®Google Scholar
• Ivanova J, Abdoli M, Nocentini A, Žalubovskis R, Supuran CT. 1,2,3-Benzoxathiazine-2,2-dioxides – efective inhibitors of human carbonic anhydrases. J Enzyme Inhib Med Chem. 2023;38(1):225–238.
   PubMed Web of Science ®Google Scholar
• Appel R, Berger G. Hydrazinesulfonic acid amide. I. Chem Ber. 1958;91(6):1339–1341.
   Google Scholar
• Chen Y-H, Lv X-J, You Z-H, Liu Y-K. Assymetric organocatalyzed reaction sequence to synthesize chiral bridged and spiro-bridged benzofused aminals via divergent pathways. Org Lett. 2019;21(14):5556–5561.
   PubMed Web of Science ®Google Scholar
• An Q, Shen J, Butt N, Liu D, Liu Y, Zhang W. Assymetric domino reaction of cyclic N-sulfonylimines and simple aldehydes with trans-perhydroindolic acid as an organocatalyst. Org Lett. 2014;16(17):4496–4499.
   PubMed Web of Science ®Google Scholar
• Fei J, Qian Q, Sun X, Gu X, Zou C, Ye J. Organocatalytic enantioselective formal [4 + 2] cycloaddition of enones with cyclic N-sulfonylimines and methylene chromene for chiral spirocyclic compounds. Org Lett. 2015;17(21):5296–5299.
   PubMed Web of Science ®Google Scholar
• Liu Q, Chen XY, Li S, Rissanen K, Enders D. N-Heterocyclic carbene catalyzed asymmetric synthesis of pentacyclic spirooxindoles via [3 + 3] annulations of isatin-derived enals and cyclic N-sulfonyl ketimines. Adv Synth Catal. 2019;361(9):1991–1994.
   Web of Science ®Google Scholar
• Cheetham KH, Hey DH. Migration reactions in polycyclic systems. II. The Fries rearrangement of 4-acetoxybiphenyl. J Chem Soc. 1937:770–772.
   Google Scholar
• Fernandes C, Soares P, Gaspar A, Martins D, Gomes LR, Low JN, Borges F. Synthesis of 6-aryl/heteroaryl-4-oxo-4H-chromene-2-carboxylic ethyl ester derivatives. Tetrahedron Lett. 2016;57(27-28):3006–3010.
   Web of Science ®Google Scholar
• Bradsher CK, Brown FC, Porter HK. Synthesis and fungistatic activity of some 3-hydroxybiphenyl derivatives. J Am Chem Soc. 1954;76(9):2357–2362.
   Web of Science ®Google Scholar
• Sheelam K, Thota P, Kottawar S, Vinnakota S, Chidara S, Yennam S, Behera M. Greener route for the synthesis of chromone using Amberlyst15 via enaminones. ARKIVOC (Gainesville, FL, United States). 2022;2022(6):55–65.
   Google Scholar
• Azimvand J. Synthesis of some new derivatives of 2-methyl-4H-4-chromenone. J Chem Pharm Res. 2012;4:3929–3933.
   Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem. 1971;246(8):2561–2573.
   PubMed Web of Science ®Google Scholar
• Pustenko A, Nocentini A, Gratteri P, Bonardi A, Vozny I, Žalubovskis R, Supuran CT. The antibiotic furagin and its derivatives are isoform-selective human carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem. 2020;35(1):1011–1020.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Carta F, Tanc M, Selleri S, Supuran CT, Bazzicalupi C, Gratteri P. Deciphering the mechanism of human carbonic anhydrases inhibition with sulfocoumarins: computational and experimental studies. Chemistry. 2018;24(31):7840–7844.
   PubMed Web of Science ®Google Scholar
• Angeli A, Carta F, Nocentini A, Winum J-Y, Zalubovskis R, Onnis V, Eldehna WM, Capasso C, Carradori S, Donald WA, et al. Response to perspectives on the classical enzyme carbonic anhydrase and the search for inhibitors. Biophys J. 2021;120(1):178–181.,.
   PubMed Web of Science ®Google Scholar
• Bua S, Bozdag M, Del Prete S, Carta F, Donald WA, Capasso C, Supuran CT. Mono- and di-thiocarbamate inhibition studies of the δ-carbonic anhydrase TweCAd from the marine diatom Thalassiosira weissflogii. J Enzyme Inhib Med Chem. 2018;33(1):707–713.
   PubMed Web of Science ®Google Scholar
• Akocak S, Lolak N, Bua S, Supuran CT. Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors. J Enzyme Inhib Med Chem. 2018;33(1):1575–1580.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Bonardi A, Gratteri P, Cerra B, Gioiello A, Supuran CT. Steroids interfere with human carbonic anhydrase activity by using alternative binding mechanisms. J Enzyme Inhib Med Chem. 2018;33(1):1453–1459.
   PubMed Web of Science ®Google Scholar
• Ivanova J, Carta F, Vullo D, Leitans J, Kazaks A, Tars K, Žalubovskis R, Supuran CT. N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII. Bioorg Med Chem. 2017;25(13):3583–3589.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? J Enzyme Inhib Med Chem. 2018;33(1):485–495.
   PubMed Web of Science ®Google Scholar
• Briganti F, Pierattelli R, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Part 37. Novel classes of carbonic anhydrase inhibitors and their interaction with the native and cobalt-substituted enzyme: kinetic and spectroscopic investigations. Eur J Med Chem. 1996;31(12):1001–1010.
   Web of Science ®Google Scholar
• Pastorekova S, Casini A, Scozzafava A, Vullo D, Pastorek J, Supuran CT. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Bioorg Med Chem Lett. 2004;14(4):869–873.
   PubMed Web of Science ®Google Scholar
• Carta F, Supuran CT, Scozzafava A. Sulfonamides and their isosters as carbonic anhydrase inhibitors. Future Med Chem. 2014;6(10):1149–1165.
   PubMed Web of Science ®Google Scholar
• Yıldırım A, Atmaca U, Keskin A, Topal M, Çelik M, Gülçin İ, Supuran CT. N-Acylsulfonamides strongly inhibit human carbonic anhydrase isoenzymes I and II. Bioorg Med Chem. 2015;23(10):2598–2605.
   PubMed Web of Science ®Google Scholar
• Davis RA, Vullo D, Maresca A, Supuran CT, Poulsen SA. Natural product coumarins that inhibit human carbonic anhydrases. Bioorg Med Chem. 2013;21(6):1539–1543.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov. 2008;7(2):168–181.
   PubMed Web of Science ®Google Scholar
• Maresca A, Scozzafava A, Supuran CT. 7,8-Disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range. Bioorg Med Chem Lett. 2010;20(24):7255–7258.
   PubMed Web of Science ®Google Scholar
• Yan Z, Wu B, Gao X, Chen M-W, Zhou Y-G. Enantioselective synthesis of α-amino phosphonates via Pd-catalyzed asymmetric hydrogenation. Org Lett. 2016;18(4):692–695.
   PubMed Web of Science ®Google Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov. 2011;10(10):767–777.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity. Expert OpinTher Pat. 2003;13(10):1545–1550.
   Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity. Expert Opin Emerg Drugs. 2012;17(1):11–15.
   PubMed Web of Science ®Google Scholar
• De Simone G, Alterio V, Supuran CT. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin Drug Disc. 2013;8(7):793–810.
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Kohsaki T, Onishi S, Takeuchi H, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: The β-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors. Bioorg Med Chem Lett. 2007;17(13):3585–3594.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Supuran CT, Carta F. Antiobesity carbonic anhydrase inhibitors: a literature and patent review. Expert Opin Ther Pat. 2013;23(6):725–735.
   PubMed Web of Science ®Google Scholar